| 2025-12-01 |
详情>>
内部人交易：
Landes Jonathan股份减少5350.00股
|
| 2025-10-23 |
详情>>
股本变动：
变动后总股本40452.01万股
|
| 2025-10-23 |
详情>>
业绩披露：
2025年三季报(累计)每股收益1.74美元,归母净利润7.21亿美元,同比去年增长16.66%
|
| 2025-10-23 |
财报披露：
美东时间 2025-10-23 盘前发布财报
|
| 2025-07-24 |
详情>>
业绩披露：
2025年中报每股收益0.98美元,归母净利润4.12亿美元,同比去年增长19.76%
|
| 2025-04-24 |
详情>>
业绩披露：
2025年一季报每股收益0.34美元,归母净利润1.42亿美元,同比去年增长-9.61%
|
| 2025-03-14 |
股东大会：
将于2025-04-25召开股东大会
会议内容 ▼▲
- 1.To elect each of our nine director nominees for a term expiring at the Company’s 2026 Annual General Meeting of Shareholders:
2.To approve, as a non-binding advisory resolution, the Company’s named executive officer compensation for the year ended December 31, 2024, as reported in the Company’s Proxy Statement
3.To approve, as a non-binding advisory resolution, an annual frequency of future Say-on-Pay proposals for Named Executive Officers
4.To approve, as a non-binding advisory resolution, the Company’s directors’ remuneration report for the year ended December 31, 2024, as reported in the Company’s U.K. Annual Report and Accounts
5.To approve the Company’s prospective directors’ remuneration policy (the “Directors’ Remuneration Policy”) for the three years ending December 31, 2027, in the form presented in the Company’s directors’ remuneration report for the year ended December 31, 2024 of the Company’s U.K. Annual Report and Accounts, such policy to take effect immediately after the conclusion of the 2025 Annual General Meeting of Shareholders
6.To receive the Company’s audited U.K. accounts for the year ended December 31, 2024, including the reports of the directors and the auditor thereon
7.To ratify the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s U.S. independent registered public accounting firm for the year ending December 31, 2025
8.To reappoint PwC as the Company’s U.K. statutory auditor under the U.K. Companies Act 2006 to hold office from the conclusion of the 2025 Annual General Meeting of Shareholders until the next annual general meeting of shareholders at which accounts are laid
9.To authorize the Board and/or the Audit Committee to determine the remuneration of PwC, in its capacity as the Company’s U.K. statutory auditor for the year ending December 31, 2025
10.To authorize the Board to allot equity securities in the Company under U.K. law
11.Pursuant to the authority contemplated by the resolution in Proposal 10, to authorize the Board to allot equity securities without pre-emptive rights under U.K. law
|
| 2025-02-27 |
详情>>
业绩披露：
2022年年报每股收益-0.24美元,归母净利润-1.07亿美元,同比去年增长-906.02%
|
| 2025-02-27 |
详情>>
业绩披露：
2024年年报每股收益1.96美元,归母净利润8.43亿美元,同比去年增长1399.82%
|
| 2024-10-24 |
详情>>
业绩披露：
2024年三季报(累计)每股收益1.44美元,归母净利润6.18亿美元,同比去年增长19218.75%
|
| 2024-07-25 |
详情>>
业绩披露：
2024年中报每股收益0.80美元,归母净利润3.44亿美元,同比去年增长495.85%
|
| 2024-04-26 |
详情>>
业绩披露：
2024年一季报每股收益0.36美元,归母净利润1.57亿美元,同比去年增长39175.00%
|
| 2024-03-15 |
股东大会：
将于2024-04-26召开股东大会
会议内容 ▼▲
- 1.To elect each of our nine director nominees for a term expiring at the Company’s 2025 Annual General Meeting of Shareholders
2.To approve, as a non-binding advisory resolution, the Company’s named executive officer compensation for the year ended December 31, 2023, as reported in the Company’s Proxy Statement
3.To approve, as a non-binding advisory resolution, the Company’s directors’ remuneration report for the year ended December 31, 2023, as reported in the Company’s United Kingdom (“U.K.”) Annual Report and Accounts
4.To approve the Company’s prospective directors’ remuneration policy for the three years ending December 31, 2027, in the form presented in the Company’s directors’ remuneration report for the year ended December 31, 2023 of the Company’s U.K. Annual Report and Accounts, such policy to take effect immediately after the conclusion of the 2024 Annual General Meeting of Shareholders
5.To receive the Company’s audited U.K. accounts for the year ended December 31, 2023, including the reports of the directors and the auditor thereon
6.To ratify the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s United States (“U.S.”) independent registered public accounting firm for the year ending December 31, 2024
7.To reappoint PwC as the Company’s U.K. statutory auditor under the U.K. Companies Act 2006, to hold office from the conclusion of the 2024 Annual General Meeting of Shareholders until the next annual general meeting of shareholders at which accounts are laid
8.To authorize the Board and/or the Audit Committee to determine the remuneration of PwC, in its capacity as the Company’s U.K. statutory auditor for the year ending December 31, 2024
9.To approve the forms of share repurchase contracts and repurchase broker-dealers in accordance with U.K. law and specific procedures for “off-market purchases” of ordinary shares through the NYSE
10.To authorize the Board to allot equity securities in the Company under U.K. law
11.Pursuant to the authority contemplated by the resolution in Proposal 10, to authorize the Board to allot equity securities without pre-emptive rights under U.K. law
|
| 2024-02-27 |
详情>>
业绩披露：
2023年年报每股收益0.13美元,归母净利润5620.00万美元,同比去年增长152.43%
|
| 2023-10-26 |
详情>>
业绩披露：
2023年三季报(累计)每股收益0.01美元,归母净利润320.00万美元,同比去年增长104.58%
|
| 2023-03-17 |
股东大会：
将于2023-04-28召开股东大会
会议内容 ▼▲
- 1.Election of Directors: To elect each of our nine director nominees for a term expiring at the Company’s 2024 Annual General Meeting of Shareholders:
2.2022 U.S. Say-on-Pay for Named Executive Officers: To approve, as a non-binding advisory resolution, the Company’s named executive officer compensation for the year ended December 31, 2022, as reported in the Company’s Proxy Statement
3.2022 U.K. Directors’ Remuneration Report: To approve, as a non-binding advisory resolution, the Company’s directors’ remuneration report for the year ended December 31, 2022, as reported in the Company’s United Kingdom (“U.K.”) Annual Report and Accounts
4.Receipt of U.K. Annual Report and Accounts: To receive the Company’s audited U.K. accounts for the year ended December 31, 2022, including the reports of the directors and the auditor thereon
5.Ratification of PwC as U.S. Auditor: To ratify the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s United States (“U.S.”) independent registered public accounting firm for the year ending December 31, 2023
6.Reappointment of PwC as U.K. Statutory Auditor: To reappoint PwC as the Company’s U.K. statutory auditor under the U.K. Companies Act 2006, to hold office from the conclusion of the 2023 Annual General Meeting of Shareholders until the next annual general meeting of shareholders at which accounts are laid
7.Approval of U.K. Statutory Auditor Fees: To authorize the Board and/or the Audit Committee to determine the remuneration of PwC, in its capacity as the Company’s U.K. statutory auditor for the year ending December 31, 2023
8.Authority to Allot Equity Securities: To authorize the Board to allot equity securities in the Company
9.Authority to Allot Equity Securities without Pre-emptive Rights: Pursuant to the authority contemplated by the resolution in Proposal 8, to authorize the Board to allot equity securities without pre-emptive rights
|
| 2022-03-18 |
股东大会：
将于2022-04-29召开股东大会
会议内容 ▼▲
- 1.To elect each of our nine director nominees for a term expiring at the Company’s 2023 Annual General Meeting of Shareholders
2.To approve, as a non-binding advisory resolution, the Company’s named executive officer compensation for the year ended December 31, 2021, as reported in the Company’s Proxy Statement
3.To approve, as a non-binding advisory resolution, the Company’s directors’ remuneration report for the year ended December 31, 2021, as reported in the Company’s U.K. Annual Report and Accounts
4.To receive the Company’s audited U.K. accounts for the year ended December 31, 2021, including the reports of the directors and the auditor thereon
5.To ratify the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s U.S. independent registered public accounting firm for the year ending December 31, 2022
6.To reappoint PwC as the Company’s U.K. statutory auditor under the U.K. Companies Act 2006, to hold office from the conclusion of the 2022 Annual General Meeting of Shareholders until the next annual general meeting of shareholders at which accounts are laid
7.To authorize the Board and/or the Audit Committee to determine the remuneration of PwC, in its capacity as the Company’s U.K. statutory auditor for the year ending December 31, 2022
8.To authorize the adoption of the TechnipFMC plc 2022 Incentive Award Plan
9.To authorize the Board to allot equity securities in the Company
Special Resolution
10.Pursuant to the authority contemplated by the resolution in Proposal 9, to authorize the Board to allot equity securities without pre-emptive rights
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-07-29 |
复牌提示：
2021-07-29 11:43:26 停牌，复牌日期 2021-07-29 12:01:14
|
| 2021-04-09 |
股东大会：
将于2021-05-20召开股东大会
会议内容 ▼▲
- 1.To elect each of our nine director nominees for a term expiring at the Company’s 2022 Annual General Meeting of Shareholders:a.Douglas J. Pferdehirt;b.Eleazar de Carvalho Filho;c. Claire S. Farley;d. Peter Mellbye;e. John O’Leary;f. Margareth ovrum;g. Kay G. Priestly;h. John Yearwood;i. Sophie Zurquiyah;
2.To approve, as a non-binding advisory resolution, the Company’s named executive officer compensation for the year ended December 31, 2020, as reported in the Company’s Proxy Statement
3.To approve, as a non-binding advisory resolution, the Company’s directors’ remuneration report for the year ended December 31, 2020, as reported in the Company’s U.K. Annual Report and Accounts
4.To approve the Company’s prospective directors’ remuneration policy for the three years ending December 2024, in the form presented in the Company’s directors’ remuneration report for the year ended December 31, 2020 of the Company’s U.K. Annual Report and Accounts, such policy to take effect immediately after the conclusion of the 2021 Annual General Meeting of Shareholders
5.To receive the Company’s audited U.K. accounts for the year ended December 31, 2020, including the reports of the directors and the auditor thereon
6.To ratify the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s U.S. independent registered public accounting firm for the year ending December 31, 2021
7.To reappoint PwC as the Company’s U.K. statutory auditor under the U.K. Companies Act 2006, to hold office from the conclusion of the 2021 Annual General Meeting of Shareholders until the next annual general meeting of shareholders at which accounts are laid
8.To authorize the Board and/or the Audit Committee to determine the remuneration of PwC, in its capacity as the Company’s U.K. statutory auditor for the year ending December 31, 2021
9.To approve the forms of share repurchase contracts and repurchase counterparties in accordance with specific procedures for “off-market purchases” of Ordinary Shares through the NYSE or Euronext Paris
10.To authorize the Board to allot equity securities in the Company
11.Pursuant to the authority contemplated by the resolution in Proposal 10, to authorize the Board to allot equity securities without pre-emptive rights
|
| 2020-03-13 |
股东大会：
将于2020-04-24召开股东大会
会议内容 ▼▲
- 1.Election of Directors: To re-elect each of our 14 director nominees for a term expiring at the Company’s 2021 Annual General Meeting of Shareholders: a. Douglas J. Pferdehirt;b. Eleazar de Carvalho Filho;c. Arnaud Caudoux;d. Pascal Colombani;e. Marie-Ange Debon;f. Claire S. Farley;g. Didier Houssin;h. Peter Mellbye;i. John O’Leary;j. Olivier Piou;k. Kay G. Priestly;l. Joseph Rinaldi
2.2019 U.S. Say-on-Pay for Named Executive Officers: To approve, as a non-binding advisory resolution, the Company’s named executive officer compensation for the year ended December 31, 2019, as reported in the Company’s Proxy Statement
3.2019 U.K. Directors’ Remuneration Report: To approve, as a non-binding advisory resolution, the Company’s directors’ remuneration report for the year ended December 31, 2019, as reported in the Company’s U.K. Annual Report and
4.Receipt of U.K. Annual Report and Accounts: To receive the Company’s audited U.K. accounts for the year ended December 31, 2019, including the reports of the directors and the auditor thereonAccounts
5.Ratification of PwC as U.S. Auditor: To ratify the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s U.S. independent registered public accounting firm for the year ending December 31, 2020
6.Reappointment of PwC as U.K. Statutory Auditor: To reappoint PwC as the Company’s U.K. statutory auditor under the U.K. Companies Act 2006, to hold office from the conclusion of the 2020 Annual General Meeting of Shareholders until the next annual general meeting of shareholders at which accounts are laid
7.Approval of U.K. Statutory Auditor Fees: To authorize the Board and/or the Audit Committee to determine the remuneration of PwC, in its capacity as the Company’s U.K. statutory auditor for the year ending December 31, 2020
|
| 2019-03-15 |
股东大会：
将于2019-05-01召开股东大会
会议内容 ▼▲
- 1.Election of Directors – by way of separate ordinary resolutions to elect each of the following 12 director nominees for a term expiring at the Company’s 2020 Annual General Meeting of Shareholders or until his or her earlier death, retirement, resignation, or removal pursuant to the Company’s articles of association (the “Articles”):
a.Douglas J. Pferdehirt
b.Arnaud Caudoux
c.Pascal Colombani
d.Marie-Ange Debon
e.Eleazar de Carvalho Filho
f.Claire S. Farley
g.Didier Houssin
h.Peter Mellbye
i.John O’Leary
j.Kay G. Priestly
k.Joseph Rinaldi
l.James M. Ringler
2.U.K. Annual Report and Accounts – ordinary resolution to receive the Company’s audited U.K. accounts for the year ended December 31, 2018, including the reports of the directors and the auditor thereon (the “U.K. Annual Report and Accounts”);
3.2018 Say-on-Pay for Named Executive Officers – ordinary resolution to approve, as a non-binding advisory resolution, the Company’s named executive officer (“NEO”) compensation for the year ended December 31, 2018, disclosed in the Proxy Statement under “Executive Compensation Discussion and Analysis” and the related compensation tables, notes, and narrative thereunder (the “Say-on-Pay Proposal for NEOs”);
4.Frequency of Future Say-on-Pay Proposals for NEOs – ordinary resolution to approve, as a non-binding advisory resolution, the frequency of future Say-on-Pay proposals for NEOs;
5.2018 Directors’ Remuneration Report – ordinary resolution to approve, as a non-binding advisory resolution, the Company’s directors’ remuneration report for the year ended December 31, 2018 (the “2018 Directors’ Remuneration Report”), in the form set out in the Company’s U.K. Annual Report and Accounts;
6.Ratification of U.S. Auditor – ordinary resolution to ratify the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s U.S. independent registered public accounting firm for the year ending December 31, 2019;
7.Re-appointment of U.K. Statutory Auditor – ordinary resolution to re-appoint PwC as the Company’s U.K. statutory auditor under the U.K. Companies Act 2006, to hold office from the conclusion of the 2019 Annual General Meeting of Shareholders until the next annual general meeting of shareholders at which accounts are laid;
8.U.K. Statutory Auditor Fees – ordinary resolution to authorize the Board and/or the Audit Committee to determine the remuneration of PwC, in its capacity as the Company’s U.K. statutory auditor for the year ending December 31, 2019.
|
| 2018-04-27 |
股东大会：
将于2018-06-14召开股东大会
会议内容 ▼▲
- 1.U.K. Annual Report and Accounts – ordinary resolution to receive the Company’s audited U.K. accounts for the year ended December 31, 2017, including the reports of the directors and the auditor thereon (the “U.K. Annual Report and Accounts”);
2.2017 Say-on-Pay for Named Executive Officers – ordinary resolution to approve, as a non-binding advisory resolution, the Company’s named executive officer (“NEO”) compensation for the year ended December 31, 2017, disclosed in the Proxy Statement under “Executive Compensation Discussion and Analysis” and the related compensation tables, notes, and narrative thereunder (the “Say-on-Pay proposal for NEOs”);
3.2017 Directors’ Remuneration Report – ordinary resolution to approve, as a non-binding advisory resolution, the Company’s directors’ remuneration report, excluding the prospective directors’ remuneration policy, as set out on pages 55 to 71 of the directors’ remuneration report for the year ended December 31, 2017 (the “2017 Directors’ Remuneration Report”), in the form set out in the Company’s U.K. Annual Report and Accounts;
4.Prospective Directors’ Remuneration Policy – ordinary resolution to approve the Company’s prospective directors’ remuneration policy for the three years ended December 2021, as set out on pages 72 to 83 of the 2017 Directors’ Remuneration Report in the form set out in the U.K. Annual Report and Accounts (the “Directors’ Remuneration Policy”), such policy to take effect immediately after the conclusion of the 2018 Annual General Meeting of Shareholders;
5.Ratification of U.S. Auditor – ordinary resolution to ratify the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s U.S. independent registered public accounting firm for the year ending December 31, 2018;
6.Re-appointment of U.K. Statutory Auditor – ordinary resolution to re-appoint PwC as the Company’s U.K. statutory auditor under the U.K. Companies Act 2006, to hold office from the conclusion of the 2018 Annual General Meeting of Shareholders until the next annual general meeting of shareholders at which accounts are laid;
7.U.K. Statutory Auditor Fees – ordinary resolution to authorize the Board and/or the Audit Committee to determine the remuneration of PwC, in its capacity as the Company’s U.K. statutory auditor for the year ending December 31, 2018, and to ratify the remuneration of PwC for the year ended December 31, 2017.
|
| 2017-10-26 |
除权日：
美东时间 2017-11-20 每股派息0.13美元
|